150 related articles for article (PubMed ID: 3493323)
1. Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc.
Morse HC; Tidmarsh GF; Holmes KL; Frederickson TF; Hartley JN; Pierce JH; Langdon WY; Dailey MO; Weissman IL
J Exp Med; 1987 Mar; 165(3):920-5. PubMed ID: 3493323
[TBL] [Abstract][Full Text] [Related]
2. Transformation-associated proteins in murine B-cell lymphomas that are distinct from Abelson virus gene products.
Pillemer E; Whitlock C; Weissman IL
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4434-8. PubMed ID: 6611551
[TBL] [Abstract][Full Text] [Related]
3. Expression of a monoclonal antibody-defined, B-lineage transformation antigen specifically identifies Abelson-diseased animals. Genetically determined resistance to Abelson murine leukemia virus acts before induction of gp160(6C3).
Tidmarsh GF; Dailey MO; Weissman IL
J Exp Med; 1986 Oct; 164(4):1356-61. PubMed ID: 3489809
[TBL] [Abstract][Full Text] [Related]
4. Transformed lymphocytes from Abelson-diseased mice express levels of a B lineage transformation-associated antigen elevated from that found on normal lymphocytes.
Tidmarsh GF; Dailey MO; Whitlock CA; Pillemer E; Weissman IL
J Exp Med; 1985 Nov; 162(5):1421-34. PubMed ID: 2997360
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis.
Brightman BK; Pattengale PK; Fan H
J Virol; 1986 Oct; 60(1):68-81. PubMed ID: 3018301
[TBL] [Abstract][Full Text] [Related]
6. Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas.
Poirier Y; Jolicoeur P
J Virol; 1989 May; 63(5):2088-98. PubMed ID: 2539505
[TBL] [Abstract][Full Text] [Related]
7. BP-1/6C3 expression defines a differentiation stage of transformed pre-B cells and is not related to malignant potential.
Ramakrishnan L; Wu Q; Yue A; Cooper MD; Rosenberg N
J Immunol; 1990 Sep; 145(5):1603-8. PubMed ID: 1974567
[TBL] [Abstract][Full Text] [Related]
8. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of c-erbB, c-myc and c-myb oncogene loci in human lymphomas and leukemias.
Roy-Burman P; Devi BG; Parker JW
Int J Cancer; 1983 Aug; 32(2):185-91. PubMed ID: 6603429
[TBL] [Abstract][Full Text] [Related]
10. Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.
Sugiyama H; Silva S; Wang YS; Weber G; Babonits M; Rosén A; Wiener F; Klein G
Int J Cancer; 1990 Nov; 46(5):845-52. PubMed ID: 2228313
[TBL] [Abstract][Full Text] [Related]
11. Expression of oncogenes in normal and transformed murine B lymphocytes.
DeCino P; Lernhardt W; Herbst H; Raschke WC
Oncogene Res; 1988; 3(1):33-7. PubMed ID: 3264606
[TBL] [Abstract][Full Text] [Related]
12. Transformation of T-lymphoid cells by Abelson murine leukemia virus.
Scott ML; Davis MM; Feinberg MB
J Virol; 1986 Aug; 59(2):434-43. PubMed ID: 2874233
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.
Brightman BK; Chandy KG; Spencer RH; Gupta S; Pattengale PK; Fan H
J Immunol; 1988 Oct; 141(8):2844-54. PubMed ID: 2902139
[TBL] [Abstract][Full Text] [Related]
15. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
16. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
17. p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.
Zou X; Cong F; Coutts M; Cattoretti G; Goff SP; Calame K
Mol Cell Biol; 2000 Jan; 20(2):628-33. PubMed ID: 10611241
[TBL] [Abstract][Full Text] [Related]
18. Oncogene expression in Rauscher murine leukemia virus induced erythroid, myeloid and lymphoid cell lines.
de Both NJ; van der Feltz MJ; Mooren A; Vermaas D; Klaassen P; Rhijnsburger EH; Kranendonk-Odijk ME
Leuk Res; 1989; 13(1):53-64. PubMed ID: 2915575
[TBL] [Abstract][Full Text] [Related]
19. Phenylhydrazine stimulates lymphopoiesis and accelerates Abelson murine leukemia virus-induced pre-B cell lymphomas.
Klinken SP; Holmes KL; Fredrickson TN; Erner SM; Morse HC
J Immunol; 1987 Nov; 139(9):3091-8. PubMed ID: 2822804
[TBL] [Abstract][Full Text] [Related]
20. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
